# Green Core

> Green Core is a VC fund in Tokyo backing Pharmaceutical and Health Care. See 8 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 8
- Last investment: Jun 2026
- Lead investor: 38%
- Last updated: Aug 2026

Green Core is an investment firm.

## Contacts

5 contacts available for Green Core. Shizune tracks 1 team members at Green Core. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/green-core?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2M–$4.8M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Pharmaceutical | 4 | 50% |
| Health Care | 3 | 38% |
| Medical | 2 | 25% |
| Biotechnology | 2 | 25% |
| Medical Device | 2 | 25% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 50% |
| Seed | 3 | 38% |
| Funding Round | 1 | 13% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ryusuke Honjo | CEO | 5 | https://shizune.co/investors/profile/ryusuke-honjo |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| JiMED | JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication. | $2M |  | Jun 18, 2026 |  |
| Cosomil | Cosomil develops early diagnostic drugs for diseases and provides research and development support to healthcare companies. |  | Series A | Feb 06, 2026 |  |
| Physiologas Technologies | Physiologas Technologies is a manufacturing company that designs and develops medical equipment for the healthcare industry. | $2M | Series A | Aug 19, 2025 |  |
| JiMED | JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication. | $2.3M | Series A | Feb 13, 2025 |  |
| Horizon Illumination Lab Optics | Horizon Illumination Lab Optics conducts programs to enhance research related to fluorescent bioimaging technology. |  | Seed | Nov 29, 2024 |  |
| A-SEEDS | A-SEEDS, an innovative biotech company sprouted from Shinshu University, is dedicated to pioneering advanced treatments for life-threatening cancers. Harnessing the potential of non-viral genetic engineering, our cutting-edge immune cell therapy opens up new horizons of hope for patients seeking effective and transformative solutions. | $3M | Seed | Jan 04, 2024 |  |
| Linqmed | Linqmed is a pharmaceutical company that specializes in the research and development of radiopharmaceuticals for cancer treatment. | $4.8M | Series A | Dec 22, 2023 |  |
| Cosomil | Cosomil develops early diagnostic drugs for diseases and provides research and development support to healthcare companies. |  | Seed | Nov 29, 2023 |  |

8 of 8 investments shown.

## Co-investors
- [Kyoto University Innovation Capital](https://shizune.co/investors/profile/kyoto-university-innovation-capital) — VC Fund, 3 deals together
- [Animal Spirits Ltd.](https://shizune.co/investors/profile/animal-spirits-ltd) — VC Fund, 2 deals together
- [ANRI](https://shizune.co/investors/profile/anri) — VC Fund, 2 deals together
- [Delight Ventures](https://shizune.co/investors/profile/delight-ventures) — VC Fund, 2 deals together
- [Keio Innovation Initiative](https://shizune.co/investors/profile/keio-innovations-initiative) — VC Fund, 2 deals together
- [Coral Capital](https://shizune.co/investors/profile/coral-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Biotechnology Investors in Japan](https://shizune.co/investors/biotechnology-investors-japan)
- [Biotechnology VC Funds in Japan](https://shizune.co/investors/biotechnology-vc-funds-japan)
- [Biotech VC Funds in Japan](https://shizune.co/investors/biotech-vc-funds-japan)
- [Medical Device Investors in Japan](https://shizune.co/investors/medical-device-investors-japan)
- [Medical Device VC Funds in Japan](https://shizune.co/investors/medical-device-vc-funds-japan)

## FAQ

### What does Green Core invest in?

Green Core invests primarily in Pharmaceutical, Health Care and Medical startups, most often at Series A and Seed stage. Most of the 8 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Green Core's check size?

Green Core typically joins rounds of $2M–$4.8M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Green Core participates in.

### How do I contact Green Core?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Green Core?

The team at Green Core includes Ryusuke Honjo (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co